Current Symptomatic and Disease-Modifying Treatments in Multiple System Atrophy

Multiple system atrophy (MSA) is a rare, severe, and rapidly progressive neurodegenerative disorder categorized as an atypical parkinsonian syndrome. With a mean life expectancy of 6–9 years after diagnosis, MSA is clinically characterized by parkinsonism, cerebellar ataxia, autonomic failure, and p...

Descripción completa

Detalles Bibliográficos
Autores principales: Mészáros, Lisa, Hoffmann, Alana, Wihan, Jeanette, Winkler, Jürgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215736/
https://www.ncbi.nlm.nih.gov/pubmed/32316335
http://dx.doi.org/10.3390/ijms21082775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215736/
https://www.ncbi.nlm.nih.gov/pubmed/32316335
http://dx.doi.org/10.3390/ijms21082775

Ejemplares similares